SB 387 amends Louisiana law to regulate pharmacy benefit managers (PBMs), directly affecting PBMs, local pharmacies, health insurers, and patients. It establishes new definitions (like "Maximum Allowable Cost List" and "Effective rate pricing"), requires PBMs to provide transparent compensation and services to enrollees and providers, and creates a private right to sue for violations. The bill also mandates audits of PBM practices, sets penalties for noncompliance, and repeals outdated provisions. These changes aim to increase transparency and accountability in how PBMs handle prescription drug pricing and reimbursements within Louisiana.
HB 211 creates Louisiana's "Homelessness Court Program," establishing specialized court divisions to address homelessness through treatment and support instead of incarceration. It directly affects individuals experiencing homelessness charged with misdemeanors or felonies related to public camping or survival needs, requiring courts to screen eligible defendants for the program. Key provisions include mandatory substance abuse and mental health treatment, housing/job assistance partnerships, and a new criminal penalty for "unauthorized camping on public property" (with exceptions for shelter access). The program aims to reduce recidivism, court workloads, and prison overcrowding by integrating health care, housing, and rehabilitation services under judicial supervision.
HB 775 modifies Louisiana law to expand when minors can consent to medical care without parental permission. It allows minors aged 13-17 to consent to treatment for pregnancy, sexually transmitted infections, substance misuse, and certain emergencies (like abuse or neglect), while requiring parental access to medical records. The bill also prohibits schools or facilities from providing preventive care to minors without parental consent and shields healthcare providers from liability for following these rules. It repeals prior provisions that permitted broader minor consent or school-based care without parental involvement. This directly affects minors, parents/guardians, healthcare providers, and schools in Louisiana.
HB 181 authorizes the Louisiana Department of Revenue to share state income tax return data with the legislative auditor exclusively to improve Medicaid program integrity. It specifically permits this data sharing to verify Medicaid eligibility accuracy, detect fraud, and comply with existing Medicaid fraud laws. The bill restricts the use of this data to these three purposes only and requires formal agreements between agencies for data sharing. This affects Medicaid program participants and administrators by enabling targeted fraud prevention through cross-agency data access.
This bill directs the state surgeon general to create a plan for updating Louisiana's informed consent procedures in medical and surgical settings. It specifically aims to address the lack of a current mechanism to review these procedures since the Medical Disclosure Panel last met in 2018. The legislation removes references to vaccinations from the scope and asks the surgeon general to include recommendations for improving the informed consent process.
This bill updates Louisiana's Anatomical Gift Act to clarify procedures and methods for making, amending, or revoking donations of human body parts for transplantation, therapy, research, or education. It directly affects donors, their agents, healthcare providers, and organizations involved in organ recovery by establishing standardized definitions and requirements for consent and authorization. Key provisions include formalizing how anatomical gifts can be recorded on driver's licenses and other identification documents, defining roles for witnesses and agents, and specifying rules for donation after brain death or circulatory death. The legislation also creates a state registry to track anatomical gift decisions and ensures consistency in how these gifts are executed and documented.
HB 106 prohibits child day care centers in Louisiana from providing melatonin (a nonprescription sleep aid) to children without written consent from a parent or legal guardian. The law directly affects day care centers and parents/guardians, requiring centers to obtain explicit permission before administering melatonin. Violations carry penalties of up to $1,000 in fines, six months in jail, or both. The bill specifically targets melatonin use in day care settings, not all nonprescription medications. It is currently pending before the Administration of Criminal Justice Committee.
HB 199 extends Louisiana's existing ban on new nursing facilities and additional nursing home beds until July 1, 2032, replacing the previous 2027 end date. This moratorium directly affects nursing facility developers, operators seeking to expand capacity, and communities planning new healthcare infrastructure. The bill modifies a specific statute (R.S. 40:2116.1(B)(1)) to set a new termination date, maintaining the current restriction without exceptions. The key change is simply prolonging the existing policy, with no new requirements or funding mechanisms added.
SB 310, the "Signs of Hope Act," requires all public high school and college/university student health centers in Louisiana to display specific signs about pregnancy resources. The signs must read "Pregnant? Help Is Available for You and Your Baby!" with a website link to Louisiana Department of Health pregnancy resources, measure at least 16x20 inches, use large readable text, and include color graphics. These signs must be placed in patient admission areas, waiting rooms, and consultation rooms by health center staff. The Louisiana Department of Health designs the signs but may accept donated signs or use donated funds to cover costs, without requiring state funds.
HB 938 requires pharmacy benefit managers (PBMs) in Louisiana to reimburse pharmacies at the National Average Drug Acquisition Cost (NADAC) plus a standard dispensing fee for all prescriptions, regardless of whether the pharmacy is independent or affiliated with the PBM. It prohibits PBMs from retaining rebates from drug manufacturers, mandating that all rebates be passed through to health plan sponsors as lower premiums, reduced patient costs, or broader coverage. The bill also limits payment errors to a 2% rate for prescription claims, establishes a formal appeal process for pharmacies disputing underpayments, and grants state regulators access to PBM data for oversight. This directly affects Louisiana pharmacies, PBMs, and health plans by standardizing payments, increasing transparency, and reducing financial disputes.
